These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 17634529)

  • 61. [Expression and clinical significance of coagulate and fibrolysis factors in tissue and plasma from hepatocellular carcinoma patients].
    Zhou Q; Liang LJ; Peng BG; Zhen YY
    Ai Zheng; 2006 Nov; 25(11):1433-8. PubMed ID: 17094916
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Differential gene expression of urokinase-type plasminogen activator and its receptor in human renal cell carcinoma.
    Bhuvarahamurthy V; Schroeder J; Kristiansen G; Roigas J; Denkert C; Johannsen M; Lein M; Loening SA; Schnorr D; Jung K; Staack A
    Oncol Rep; 2005 Sep; 14(3):777-82. PubMed ID: 16077991
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Prevention of breast cancer growth, invasion, and metastasis by antiestrogen tamoxifen alone or in combination with urokinase inhibitor B-428.
    Xing RH; Mazar A; Henkin J; Rabbani SA
    Cancer Res; 1997 Aug; 57(16):3585-93. PubMed ID: 9270032
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A hybrid protein comprising ATF domain of pro-UK and VAS, an angiogenesis inhibitor, is a potent candidate for targeted cancer therapy.
    Sun Q; Xu Q; Dong X; Cao L; Huang X; Hu Q; Hua ZC
    Int J Cancer; 2008 Aug; 123(4):942-50. PubMed ID: 18528863
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Urokinase plasminogen activator, uPa receptor, and its inhibitor in vernal keratoconjunctivitis.
    Leonardi A; Brun P; Sartori MT; Cortivo R; Dedominicis C; Saggiorato G; Abatangelo G; Secchi AG
    Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1364-70. PubMed ID: 15790903
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Significant down-regulation of the plasminogen activator inhibitor 1 mRNA in pancreatic cancer.
    Warnecke-Eberz U; Prenzel KL; Baldus SE; Metzger R; Dienes HP; Bollschweiler E; Hoelscher AH; Schneider PM
    Pancreas; 2008 Mar; 36(2):173-7. PubMed ID: 18376309
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Urokinase plasminogen activator receptor promotes macrophage infiltration into the vascular wall of ApoE deficient mice.
    Gu JM; Johns A; Morser J; Dole WP; Greaves DR; Deng GG
    J Cell Physiol; 2005 Jul; 204(1):73-82. PubMed ID: 15573379
    [TBL] [Abstract][Full Text] [Related]  

  • 68. In situ gene expression of urokinase-type plasminogen activator and its receptor in transitional cell carcinoma of the human bladder.
    Bhuvarahamurthy V; Schroeder J; Denkert C; Kristiansen G; Schnorr D; Loening SA; Jung K; Staack A
    Oncol Rep; 2004 Oct; 12(4):909-13. PubMed ID: 15375521
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Increased invasion of neuroglioma cells transfected with urokinase plasminogen activator receptor cDNA.
    Mohanam S; Chintala SK; Mohan PM; Sawaya R; Lagos GK; Gokaslan ZL; Kouraklis GP; Rao JS
    Int J Oncol; 1998 Dec; 13(6):1285-90. PubMed ID: 9824646
    [TBL] [Abstract][Full Text] [Related]  

  • 70. MMP-9, uPAR and cathepsin B silencing downregulate integrins in human glioma xenograft cells in vitro and in vivo in nude mice.
    Veeravalli KK; Chetty C; Ponnala S; Gondi CS; Lakka SS; Fassett D; Klopfenstein JD; Dinh DH; Gujrati M; Rao JS
    PLoS One; 2010 Jul; 5(7):e11583. PubMed ID: 20657647
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Simultaneous downregulation of uPAR and MMP-9 induces overexpression of the FADD-associated protein RIP and activates caspase 9-mediated apoptosis in gliomas.
    Gondi CS; Dinh DH; Gujrati M; Rao JS
    Int J Oncol; 2008 Oct; 33(4):783-90. PubMed ID: 18813792
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Regulation and role of urokinase plasminogen activator in vascular remodelling.
    Tkachuk V; Stepanova V; Little PJ; Bobik A
    Clin Exp Pharmacol Physiol; 1996 Sep; 23(9):759-65. PubMed ID: 8911711
    [TBL] [Abstract][Full Text] [Related]  

  • 73. uPA and uPAR shRNA inhibit angiogenesis via enhanced secretion of SVEGFR1 independent of GM-CSF but dependent on TIMP-1 in endothelial and glioblastoma cells.
    Raghu H; Nalla AK; Gondi CS; Gujrati M; Dinh DH; Rao JS
    Mol Oncol; 2012 Feb; 6(1):33-47. PubMed ID: 22177802
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Lysophosphatidylcholine induces urokinase-type plasminogen activator and its receptor in human macrophages partly through redox-sensitive pathway.
    Oka H; Kugiyama K; Doi H; Matsumura T; Shibata H; Miles LA; Sugiyama S; Yasue H
    Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):244-50. PubMed ID: 10634825
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Biological significance of the expression of urokinase-type plasminogen activator receptors (uPARs) in brain tumors.
    Mohanam S; Gladson CL; Rao CN; Rao JS
    Front Biosci; 1999 Feb; 4():D178-87. PubMed ID: 9989951
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Activation of urokinase plasminogen activator and its receptor axis is essential for macrophage infiltration in a prostate cancer mouse model.
    Zhang J; Sud S; Mizutani K; Gyetko MR; Pienta KJ
    Neoplasia; 2011 Jan; 13(1):23-30. PubMed ID: 21245937
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Dynamic assembly of the urokinase-type plasminogen activator signaling receptor complex determines the mitogenic activity of urokinase-type plasminogen activator.
    Jo M; Thomas KS; Marozkina N; Amin TJ; Silva CM; Parsons SJ; Gonias SL
    J Biol Chem; 2005 Apr; 280(17):17449-57. PubMed ID: 15728176
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Effect of RNA interference targeting-survivin on the invasiveness of human glioma cells in vitro].
    Shi DG; Fan Y; Zhu F; Zhang JR
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jun; 29(6):1156-8. PubMed ID: 19726348
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Epidermal growth factor receptor-mediated regulation of urokinase plasminogen activator expression and glioblastoma invasion via C-SRC/MAPK/AP-1 signaling pathways.
    Amos S; Redpath GT; Dipierro CG; Carpenter JE; Hussaini IM
    J Neuropathol Exp Neurol; 2010 Jun; 69(6):582-92. PubMed ID: 20467333
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A novel role for the urokinase-type plasminogen activator receptor in apoptosis of malignant gliomas.
    Kin Y; Chintala SK; Go Y; Sawaya R; Mohanam S; Kyritsis AP; Rao JS
    Int J Oncol; 2000 Jul; 17(1):61-5. PubMed ID: 10853019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.